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Abstract
Objective
To investigate optimal timing of elective repeat caesarean section among low-risk pregnant
women with prior caesarean section in a multicountry sample from largely low- and middle-
income countries.
Design
Secondary analysis of a cross-sectional study.
Setting
Twenty-nine countries from the World Health Organization Multicountry Survey on Maternal
and Newborn Health.
Population
29,647 women with prior caesarean section and no pregnancy complications in their current
pregnancy who delivered a term singleton (live birth and stillbirth) at gestational age 37–41
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weeks by pre-labour caesarean section, intra-partum caesarean section, or vaginal birth fol-
lowing spontaneous onset of labour.
Methods
We compared the rate of short-term adverse maternal and newborn outcomes following
pre-labour caesarean section at a given gestational age, to those following ongoing preg-
nancies beyond that gestational age.
Main OutcomeMeasures
Severe maternal outcomes, neonatal morbidity, and intra-hospital early neonatal mortality.
Results
Odds of neonatal morbidity and intra-hospital early neonatal mortality were 0.48 (95% confi-
dence interval [CI] 0.39–0.60) and 0.31 (95% CI 0.16–0.58) times lower for ongoing preg-
nancies compared to pre-labour caesarean section at 37 weeks. We did not find any
significant change in the risk of severe maternal outcomes between pre-labour caesarean
section at a given gestational age and ongoing pregnancies beyond that gestational age.
Conclusions
Elective repeat caesarean section at 37 weeks had higher risk of neonatal morbidity and
mortality compared to ongoing pregnancy, however risks at later gestational ages did not
differ between groups.
Introduction
Over the last two decades, rates of caesarean section (CS) have increased around the world [1].
Approximately 15% of births worldwide are by CS [2], and CS rates exceed 30% in several
high-income countries and Latin American countries [1]. This trend has led to an increase in
the number of post-CS pregnancies. Pregnant women with prior CS and their fetuses are at
higher risk of maternal/perinatal complications, including placenta accreta, uterine rupture,
blood transfusion, hysterectomy, and maternal/fetal death [3–6]. Even in many sub-Saharan
African countries where CS rates remain relatively low, proportionately more women are gain-
ing access to CS [7], and the safety of post-CS pregnancies is a growing concern [8].
The safest mode of childbirth for pregnant women with prior CS remains a matter of debate.
The birth plan options for women with prior CS include elective repeat caesarean section
(ERCS) and trial of labour after caesarean delivery (TOLAC). For women who choose to have
ERCS, the optimal timing of ERCS is also important. Numerous studies have reported the rela-
tionship between increased risk of neonatal complications, especially respiratory disorders,
with elective CS before 39 weeks [9–12]. In previous research, optimal timing of ERCS has
mainly been discussed in light of reducing neonatal complications, and delaying elective CS to
39 weeks is advocated in several high-income countries [13–16]. However, around 10% of
women are reported to go into labour before 39 weeks [17].
Pregnant women with prior CS could be considered as a specific patient group in need of an
appropriate birth plan, obstetrical management, and medical resources in order to achieve safe
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delivery. However, labour and childbirth in women with prior CS in developing countries may
present additional challenges, such as differences in CS quality and safety, limited access to
medical services, and variable capacity of health facilities. Thus, it is important to explore these
factors to increase knowledge on this issue, to develop appropriate birth plans for post-CS
pregnancies, and to ensure better care for mothers and their babies.
This study is a secondary analysis of the World Health Organization Multicountry Survey
on Maternal and Newborn Health (WHOMCS), a large multicenter cross-sectional survey of
deliveries in 29 countries. In this study, we sought to explore the optimal timing of ERCS
among low-risk pregnant women with prior CS by assessing the benefits and risks of pre-
labour CS at a given gestational age (GA) compared to ongoing pregnancies beyond that GA.
Materials and Methods
Study design and data collection
The present study is a secondary data analysis of the WHOMCS. A multistage cluster sampling
method was used to select 359 health facilities in two randomly selected provinces and capital
cities from 29 countries in Africa, Asia, Latin America and the Middle East. Methodology and
implementation of this study have been published in detail elsewhere [18, 19]. In participating
facilities, all women who gave birth, had severe maternal morbidity regardless of GA and deliv-
ery status, or who died during pregnancy, delivery or within seven days postpartum, were
recruited during the study period from 1 May 2010 to 31 December 2011. Data collection took
place at the individual and facility levels. Trained medical staff at these facilities retrieved infor-
mation from medical records, including individual data on demographics and reproductive
characteristics, medical conditions during pregnancy, birth outcomes, complications, and
received interventions. Data were collected without any personal identifiers of the study partic-
ipants, and no information was obtained directly from the study participants. Hence, individ-
ual informed consent from the study participants was considered not necessary and was not
obtained. Characteristics of each health facility capacity, such as the capabilities of the infra-
structure, essential and comprehensive obstetric and neonatal healthcare services, and the facil-
ity’s capability to identify and manage severe complications, were obtained through an
institutional survey that was completed by the head of the facility or the obstetrics department.
Data were collected for two months in facilities with more than 6,000 deliveries per year, and
for three months in facilities with less than 6,000 deliveries per year. All data was anonymized
and de-identified prior to analysis. The UNDP/UNFPA/UNICEF/WHO/World Bank Special
Programme of Research, Development and Research Training in Human Reproduction (HRP)
Specialist Panel on Epidemiological Research reviewed and approved the study protocol for
technical content. This study was approved by the WHO Ethical Review Committee and the
relevant ethical clearance mechanisms in all countries (protocol ID: A65661; date of approval
27 October 2009).
Study population
The population of interest in the present study is women with prior CS who had no pregnancy
complications in their current pregnancy and gave birth to a term (i.e. 37 to 41 weeks) single-
ton (live birth or stillbirth). Of the 314,623 women who participated in the WHOMCS, a total
of 38,053 women had a prior CS. We excluded women with medical conditions during preg-
nancy and childbirth, including severe anaemia (defined as haemoglobin (Hb)<7mg/dl),
malaria or dengue fever, preeclampsia/eclampsia, and other conditions, such as disease or
injury affecting the heart, lungs, kidney or liver (n = 2,622). In addition, multifetal births
(n = 483), congenital malformations (n = 316), deliveries with induction (n = 1,870), and
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women with missing data on gestational age, onset of labour, fetal presentation, birth weight,
and either infant status at birth or seventh day of life (n = 533), were not included in the analy-
sis. As shown in Fig 1, the final analytic sample comprised 29,647 women with prior CS, of
whom in the current pregnancy 13,576 had pre-labour CS and 16,071 delivered following
spontaneous onset of labour.
Variables and definitions
Gestational age was reported in WHOMCS by completed weeks. To explore the benefits and
risks of repeat CS in the absence of labour at a given GA, it is necessary to compare the rate of
adverse outcomes of “pre-labour CS” (i.e. repeat CS in the absence of labour) at a given GA to
all “ongoing pregnancies” beyond that GA (i.e. all deliveries at a later GA). We assigned to the
pre-labour CS group those women who underwent repeat CS at a given GA in the absence of
labour. Those who had spontaneous labour at the same GA were excluded from this group. By
excluding these women, we defined the pre-labour CS group as a proxy group of women who
had ERCS at the given GA. We also assigned women with ongoing pregnancies who delivered
at a later GA to the ongoing pregnancy group, and they would either undergo pre-labour CS or
spontaneous labour resulting in intra-partum CS or vaginal birth after caesarean (VBAC) at a
later GA. We also defined intra-partum CS as CS after spontaneous onset of labour. In order to
obtain the most similar proxy for a group of women who were scheduled for ERCS, we
excluded women who had induction of labour from our analysis, since having induction of
labour means that those women were scheduled for TOLAC.
In this analysis, we assessed adverse maternal and perinatal outcomes that have previously
been described [19–21]. Severe maternal outcomes (SMO) were defined as maternal death or
maternal near-miss (MNM) cases that occurred on or before the eighth day postpartum.
MNM was defined as women with life-threatening conditions (i.e., failure or dysfunction of
any of the vital organ systems including circulatory, respiratory, cardiac, renal, hepatic, central
nervous, metabolic and haematological) who almost died but survived pregnancy, childbirth or
abortion, and were identified by the WHO criteria (S1 Table) [22].
Fig 1. Flow chart of study population.
doi:10.1371/journal.pone.0149091.g001
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Adverse neonatal outcomes included early neonatal morbidity and mortality. Neonatal
morbidity or neonatal near-miss cases were identified based on management criteria proposed
elsewhere [23], which measure the need or use of any of the following lifesaving interventions
until the seventh day of neonatal life: any intubation, nasal continuous positive airway pressure,
surfactant administration, cardio-pulmonary resuscitation (cardiac massage), any surgery, use
of any vasoactive drug, use of any blood products, anticonvulsants, phototherapy in the first 24
hours after birth, steroids to treat refractory hypoglycemia, or therapeutic intravenous antibiot-
ics [23]. Intra-hospital early neonatal mortality (IHENM) was defined as the death of a live-
born neonate in participating facilities within the first week of life or before hospital discharge.
Covariates included in the analysis were: maternal age (<20, 20–34,35), maternal educa-
tion (6, 7–12,>12 years), marital status (single or married/cohabiting), number of prior CS
(1, 2,3), health facility capacity (high, medium, low) and countries’Human Development
Index (HDI) based on the 2012 rankings (very high and high, medium, low). In the WHOMCS,
detailed information regarding the participating health facilities’ characteristics and capacities
was collected using a structured questionnaire. Using these data, facility capacity index was cre-
ated and calculated as the total score of available services comprising six categories: standard of
building/basic services, medical services, emergency obstetric services, laboratory tests, hospital
practices, and human resources. Based on its facility capacity index, each facility was further
categorized into low, medium, and high [19].
Analysis and statistical methods
We described the characteristics of the study population, GA at birth, and mode of delivery.
We compared the risks of adverse maternal/neonatal outcomes between the pre-labour CS
group and the ongoing pregnancies group at a given GA. For instance, we compared pre-labour
CS at 37 weeks with deliveries after 37 weeks, pre-labour CS at 38 weeks with deliveries after 38
weeks, and pre-labour CS at 39 weeks with deliveries after 39 weeks. Neonatal morbidity,
IHENM, and SMO in the pre-labour CS group at a given GA were calculated by dividing the
number of events at that GA by the number of total deliveries at the same GA. Neonatal mor-
bidity, IHENM, and SMO in the ongoing pregnancy group beyond that GA were calculated by
dividing the number of events after that GA by the number of total deliveries after that GA.
These measures allowed us to compare the risk of adverse outcomes between different gesta-
tional lengths, as well as between delivery and continuation of pregnancies at a given GA [24–
27]. Crude odds ratios were adjusted for study design (i.e. health facilities as sampling units
and countries as strata). We fitted multilevel logistic regression models with random effects of
health facilities and adjusted for maternal age, educational level, marital status, number of pre-
vious CS, health facility capacity, and countries’HDI. We reported all adjusted odds ratios with
corresponding 95% confidence intervals (95% CI). Missing values were excluded from all logis-
tic regression models. Statistical analysis was conducted using Stata/MP version 13.0 (Stata-
Corp LP, College Station, Texas, USA).
Results
Data were analyzed from 29,647 women who had CS in their previous pregnancy, had no preg-
nancy complications in the index pregnancy, and gave birth to a term singleton (Fig 1).
Table 1 shows the characteristics of all women included in this study. The majority of
women were aged between 20–34 years (79.0%), married or cohabiting (93.1%), and had one
prior CS (77.8%). Approximately half of the women had spontaneous onset of labour, and
35.9% of all women delivered by intra-partum CS. Most women delivered either at 38 or 39
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weeks (33.8% and 27.0%). About 40% of women who delivered were in very high and high
HDI countries, and 46.8% of deliveries took place at health facilities with medium capacity.
Fig 2 shows the flow diagram of the study groups used for comparison of adverse maternal/
neonatal outcomes between pre-labour CS at a given GA and ongoing pregnancies beyond that
GA. Table 2 shows adverse maternal and neonatal outcomes for pre-labour CS and ongoing
pregnancies at each GA from 37 to 40 weeks. After adjusting for maternal age, education, mari-
tal status, number of previous CS, capacity of facility and country HDI, the odds of neonatal
morbidity and IHENM were 0.48 (95% CI 0.39–0.60) and 0.31 (95% CI 0.16–0.58) times lower
Table 1. Characteristics of study population.
Characteristics No. of women %
Maternal age (n = 29,647)
19 years 779 2.6
20–34 years 2,3421 79.0
35 years 5,447 18.4
Marital status (n = 29,430)
Single 2,034 6.9
Married/cohabiting 27,396 93.1
Education (n = 29,647)
6 years 6,101 20.6
7–12 years 15,062 50.8
>12 years 8,484 28.6
Number of previous CS (n = 29,647)
1 23,064 77.8
2 5,413 18.2
3 1,170 4.0
Gestational age at delivery (n = 29,647)
37 weeks 4,297 14.5
38 weeks 10,028 33.8
39 weeks 8,012 27.0
40 weeks 6,004 20.3
41 weeks 1,306 4.4
Fetal presentation (n = 29,647)
Cephalic 27,996 94.4
Breech/other 1,651 5.6
Mode of delivery (n = 29,647)
Pre-labour CS 13,576 45.8
Intra-partum CS 10,656 35.9
Vaginal delivery 5,415 18.3
Facility score (n = 25,812)
High 9,886 38.3
Medium 12,079 46.8
Low 3,847 14.9
HDI country groups (n = 29,647)
Very high and high 12,019 40.6
Medium 9,584 32.3
Low 8,044 27.1
CS, caesarean section; HDI, Human Development Index as of 2012
doi:10.1371/journal.pone.0149091.t001
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for ongoing pregnancies compared to pre-labour CS at 37 weeks. We also conducted the same
analysis by HDI groups; the subgroup analysis also showed higher risk of neonatal morbidity
among neonates born by pre-labour CS at 37 weeks consistently across all HDI groups (S2
Table). In addition, a sensitivity analysis was conducted to see whether the results would
change in women with only one prior CS and women with more than one prior CS (S3 and S3a
Table); however, the results were the same.
Description of participating countries’mode and timing of delivery after prior CS and dis-
tribution of adverse maternal/neonatal outcomes were presented in S4 Table and S1 Fig.
Discussion
To our knowledge, this is the first report to describe timing of delivery among low-risk women
with prior CS in a multicountry sample from largely low- and middle-income countries. Our
analysis showed wide variation in timing of delivery among women with prior CS at health
facilities across the participating countries. We noted that pre-labour CS at 37 weeks had a sig-
nificantly increased risk of neonatal morbidity and early neonatal mortality in comparison
Fig 2. Flow diagram of study group comparing pre-labour CS at a given GA to deliveries at a later GA.
doi:10.1371/journal.pone.0149091.g002
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with ongoing pregnancies beyond 37 weeks. We did not find any significant change in the risk
of SMO between pre-labour CS at a given GA and ongoing pregnancies beyond that GA.
Optimal timing of ERCS is ideally the GA at which the risk of adverse maternal and neona-
tal outcomes is minimized. In previous studies, 39 weeks was identified as a threshold GA
related to minimized risks of neonatal morbidity and mortality [9–12], and ERCS before 39
weeks was not associated with decreased maternal risk [28]. However, these observational stud-
ies assessing risks of ERCS at a certain GA have often compared maternal and neonatal out-
comes by GA among women who had ERCS without labour [9–12, 28]. This method discounts
risks of adverse events, including those following spontaneous onset of labour which could be
avoided by earlier ERCS. Therefore, following several previous studies on optimal timing of
delivery and obstetrical interventions [24–27], we compared maternal and neonatal outcomes
of pregnancies delivered by pre-labour CS at a certain GA to those receiving expectant manage-
ment, i.e., pregnancies that were delivered beyond that GA. Using this method, it was indicated
that delaying CS beyond 37 weeks significantly reduces morbidity and mortality risk for the
neonate.
Delaying ERCS provides time for the fetus to mature, leading to reduced neonatal mortality
and morbidity. On the other hand, delaying ERCS increases risk of spontaneous labour before
the day of scheduled ERCS, which could lead to life-threatening events such as uterine rupture
if emergency CS is not readily available [29]. Earlier ERCS may be beneficial in resource-lim-
ited settings to avoid this situation. We therefore expected a higher risk of SMO among women
Table 2. Comparison between pre-labour CS at a given GA and all ongoing pregnancies beyond that GA.
GA Outcomes Pre-labour CS Ongoing pregnancies§ Odds ratio† (95% CI) AOR ††(95% CI)
n (%) n (%)
37 weeks Deliveries 2,271 25,350
SMO 10 (0.4%) 68 (0.3%) 0.61 (0.30–1.21) 0.70 (0.34–1.42)
Neonatal morbidity 138 (6.1%) 837 (3.3%) 0.53 (0.41–0.67)** 0.48 (0.39–0.60)**
IHENM 17 (0.8%) 74 (0.3%) 0.39 (0.22–0.69)* 0.31 (0.16–0.58)**
38 weeks Deliveries 5,470 15,322
SMO 16 (0.3%) 37 (0.2%) 0.83 (0.44–1.55) 0.78 (0.38–1.60)
Neonatal morbidity 192 (3.5%) 473 (3.1%) 0.88 (0.67–1.15) 0.82 (0.66–1.02)
IHENM 9 (0.2%) 46 (0.3%) 1.84 (0.89–3.77) 2.01 (0.82–4.93)
39 weeks Deliveries 3,560 7,310
SMO 5 (0.1%) 21 (0.3%) 2.05 (0.74–5.61) 1.82 (0.61–5.45)
Neonatal morbidity 110 (3.1%) 226 (3.1%) 1.01 (0.72–1.42) 0.92 (0.68–1.23)
IHENM 7 (0.2%) 26 (0.4%) 1.83 (0.82–4.07) 1.29 (0.49–3.33)
40 weeks Deliveries 1,857 1,306
SMO 5 (0.3%) 5 (0.4%) 1.42 (0.41–4.92) 1.01 (0.21–4.99)
Neonatal morbidity 56 (3.0%) 51 (4.0%) 1.31 (0.85–2.03) 1.12 (0.70–1.80)
IHENM 5(0.3%) 5 (0.4%) 1.43 (0.37–5.46) 1.67 (0.38–7.36)
AOR, adjusted odds ratio; CS, caesarean section; GA, gestational age; HDI, Human Development Index as of 2012; IHENM, intra-hospital early neonatal
death; SMO, severe maternal outcomes.
§ Includes all ongoing pregnancies after given gestational age.
† Calculation of crude odds ratio adjusted for clustering due to survey design.
†† Multi-level logistic regression with random effects for health facilities and adjustments made for maternal age, education, marital status, number of
previous CS, capacity of facility, and country HDI
*p<0.05
**p<0.01
doi:10.1371/journal.pone.0149091.t002
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who did not deliver until a later GA. However, this study failed to show that ERCS at an earlier
GA reduces risk of SMO. Our results should be interpreted with caution, as we excluded
women with pregnancy complications in order to analyse outcomes in low-risk women. Cer-
tain complications may reasonably warrant intervention at an earlier GA, and further research
for these sub-groups is required. In this analysis, the numbers of the events were small espe-
cially at later GAs, and might not be sufficient to test the significance.
Our study had several limitations. First, a lack of information about initial birth plans was a
major challenge in determining optimal timing of ERCS, and an inherent limitation of such
studies so far. As “scheduling” an ERCS at a certain GA is in itself an intervention, an ideal
study design to determine the optimal timing of ERCS would be to compare maternal and peri-
natal outcomes across the GA for which ERCS was scheduled, regardless of when and how the
women actually gave birth. Second, the documented GA was the best obstetric estimate based
on local practices. The method of GA assessment for individual women was not captured, and
likely varied between health facilities. The error margin for GA may be a factor, as misclassifi-
cation of GA could affect the results. Third, risk of fetal death due to delayed delivery should
also be considered in addition to maternal and neonatal adverse outcomes discussing optimal
timing of delivery, since certain types of fetal death could be averted by earlier delivery [30].
However, we could not further evaluate the reduced risk of FD by earlier ERCS as we did not
have data on when and how FD occurred. Fourth, due to the nature of the WHOMCS, we
could only focus on selected short-term outcomes up to the time of discharge or seventh post-
partum day for neonates and eighth postpartum day for mothers. Information on long-term
outcomes, such as neonatal death (deaths within the first 28 days of neonatal life) and the
ongoing health and development of children, was outside the scope of WHOMCS. Fifth, clini-
cal information regarding the prior CS procedure itself could potentially affect the outcomes of
the present pregnancy, however these were not captured in WHOMCS. Sixth, since this is a
facility-based study of facilities with CS capacity and over 1,000 deliveries per year, the popula-
tion in this study may not be representative of populations in countries or other facility types.
Lastly, as our analysis explored the association between timing of pre-labour CS and adverse
outcomes in a setting where practice is likely to differ between facilities, we cannot deny the
possibility that correlation between institutional practice patterns regarding GA at ERCS and
their overall performance biased the results. However, since we conducted multilevel analysis
which accounted for facility difference, such possible bias was minimized.
Conclusions
Our analysis showed that ERCS at 37 weeks was associated with a higher risk of early neonatal
mortality and morbidity compared to those in later weeks. As there is still uncertainty regard-
ing the relative risks and benefits of scheduling ERCS at a certain GA, these findings should be
interpreted with caution. Further studies are warranted to confirm these risks and benefits, and
to determine the optimal timing of ERCS for both low- and higher-risk women.
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